{
  "input": {
    "mode": "revise",
    "query": {
      "entity": "Severe hypertriglyceridaemia",
      "relation": "contraindication"
    },
    "tegraph_snapshot": {
      "nodes": [
        {
          "id": "drug_gemfibrozil",
          "type": "Drug",
          "label": "Gemfibrozil",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_fenofibrate",
          "type": "Drug",
          "label": "Fenofibrate",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_clofibrate",
          "type": "Drug",
          "label": "Clofibrate",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_niacin",
          "type": "Drug",
          "label": "Niacin",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_estrogens",
          "type": "Drug",
          "label": "Estrogens",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_thiazolidinediones",
          "type": "Drug",
          "label": "Thiazolidinediones",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_sodium_glucose_cotransporter_2_inhibitors",
          "type": "Drug",
          "label": "Sodium-glucose cotransporter-2 inhibitors",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_corticosteroids",
          "type": "Drug",
          "label": "Corticosteroids",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_bosentan",
          "type": "Drug",
          "label": "Bosentan",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_glitazones",
          "type": "Drug",
          "label": "Glitazones",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_beta_blockers",
          "type": "Drug",
          "label": "Beta-blockers",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_progestins",
          "type": "Drug",
          "label": "Progestins",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "Severe_hypertriglyceridaemia",
          "type": "Disease",
          "label": "Severe Hypertriglyceridaemia",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_rp_gemfibrozil",
          "type": "Pathway",
          "label": "RiskPathwayGemfibrozil",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_adv_gemfibrozil",
          "type": "Phenotype",
          "label": "AdversePhenotypeGemfibrozil",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_rp_fenofibrate",
          "type": "Pathway",
          "label": "RiskPathwayFenofibrate",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_adv_fenofibrate",
          "type": "Phenotype",
          "label": "AdversePhenotypeFenofibrate",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_rp_clofibrate",
          "type": "Pathway",
          "label": "RiskPathwayClofibrate",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_adv_clofibrate",
          "type": "Phenotype",
          "label": "AdversePhenotypeClofibrate",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_rp_niacin",
          "type": "Pathway",
          "label": "RiskPathwayNiacin",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_adv_niacin",
          "type": "Phenotype",
          "label": "AdversePhenotypeNiacin",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_rp_estrogens",
          "type": "Pathway",
          "label": "RiskPathwayEstrogens",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_adv_estrogens",
          "type": "Phenotype",
          "label": "AdversePhenotypeEstrogens",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_rp_thiazolidinediones",
          "type": "Pathway",
          "label": "RiskPathwayThiazolidinediones",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_adv_thiazolidinediones",
          "type": "Phenotype",
          "label": "AdversePhenotypeThiazolidinediones",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_rp_sodium_glucose_cotransporter_2_inhibitors",
          "type": "Pathway",
          "label": "RiskPathwaySGLT2Inhibitors",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_adv_sodium_glucose_cotransporter_2_inhibitors",
          "type": "Phenotype",
          "label": "AdversePhenotypeSGLT2Inhibitors",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_rp_corticosteroids",
          "type": "Pathway",
          "label": "RiskPathwayCorticosteroids",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_adv_corticosteroids",
          "type": "Phenotype",
          "label": "AdversePhenotypeCorticosteroids",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_rp_bosentan",
          "type": "Pathway",
          "label": "RiskPathwayBosentan",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_adv_bosentan",
          "type": "Phenotype",
          "label": "AdversePhenotypeBosentan",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_rp_glitazones",
          "type": "Pathway",
          "label": "RiskPathwayGlitazones",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_adv_glitazones",
          "type": "Phenotype",
          "label": "AdversePhenotypeGlitazones",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_rp_beta_blockers",
          "type": "Pathway",
          "label": "RiskPathwayBetaBlockers",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_adv_beta_blockers",
          "type": "Phenotype",
          "label": "AdversePhenotypeBetaBlockers",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_rp_progestins",
          "type": "Pathway",
          "label": "RiskPathwayProgestins",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_adv_progestins",
          "type": "Phenotype",
          "label": "AdversePhenotypeProgestins",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "H1",
          "type": "Hypothesis",
          "label": "Gemfibrozil",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H2",
          "type": "Hypothesis",
          "label": "Fenofibrate",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H3",
          "type": "Hypothesis",
          "label": "Clofibrate",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H4",
          "type": "Hypothesis",
          "label": "Niacin",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H5",
          "type": "Hypothesis",
          "label": "Estrogens",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H6",
          "type": "Hypothesis",
          "label": "Thiazolidinediones",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H7",
          "type": "Hypothesis",
          "label": "Sodium-glucose cotransporter-2 inhibitors",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H8",
          "type": "Hypothesis",
          "label": "Corticosteroids",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H9",
          "type": "Hypothesis",
          "label": "Bosentan",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H10",
          "type": "Hypothesis",
          "label": "Glitazones",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H11",
          "type": "Hypothesis",
          "label": "Beta-blockers",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H12",
          "type": "Hypothesis",
          "label": "Progestins",
          "attrs": {
            "agent": "PI"
          }
        }
      ],
      "edges": [
        {
          "source": "drug_gemfibrozil",
          "target": "Severe_hypertriglyceridaemia",
          "relation": "inhibits",
          "weight": 0.8,
          "agent": "Proponent",
          "rationale": "Gemfibrozil常用于降低血脂"
        },
        {
          "source": "drug_fenofibrate",
          "target": "Severe_hypertriglyceridaemia",
          "relation": "inhibits",
          "weight": 0.8,
          "agent": "Proponent",
          "rationale": "Fenofibrate常用于降低血脂"
        },
        {
          "source": "drug_clofibrate",
          "target": "Severe_hypertriglyceridaemia",
          "relation": "inhibits",
          "weight": 0.7,
          "agent": "Proponent",
          "rationale": "Clofibrate用于高甘油三酯血症"
        },
        {
          "source": "drug_niacin",
          "target": "Severe_hypertriglyceridaemia",
          "relation": "inhibits",
          "weight": 0.7,
          "agent": "Proponent",
          "rationale": "Niacin可降低甘油三酯"
        },
        {
          "source": "drug_estrogens",
          "target": "Severe_hypertriglyceridaemia",
          "relation": "inhibits",
          "weight": 0.6,
          "agent": "Proponent",
          "rationale": "雌激素影响脂质代谢"
        },
        {
          "source": "drug_thiazolidinediones",
          "target": "Severe_hypertriglyceridaemia",
          "relation": "inhibits",
          "weight": 0.5,
          "agent": "Proponent",
          "rationale": "改善胰岛素敏感性可能降低甘油三酯"
        },
        {
          "source": "drug_sodium_glucose_cotransporter_2_inhibitors",
          "target": "Severe_hypertriglyceridaemia",
          "relation": "inhibits",
          "weight": 0.5,
          "agent": "Proponent",
          "rationale": "有助于减轻体重，从而影响血脂"
        },
        {
          "source": "drug_corticosteroids",
          "target": "Severe_hypertriglyceridaemia",
          "relation": "inhibits",
          "weight": 0.4,
          "agent": "Proponent",
          "rationale": "皮质类固醇可影响脂肪代谢"
        },
        {
          "source": "drug_bosentan",
          "target": "Severe_hypertriglyceridaemia",
          "relation": "inhibits",
          "weight": 0.4,
          "agent": "Proponent",
          "rationale": "可能影响脂质代谢"
        },
        {
          "source": "drug_glitazones",
          "target": "Severe_hypertriglyceridaemia",
          "relation": "inhibits",
          "weight": 0.4,
          "agent": "Proponent",
          "rationale": "改善糖尿病可能降低甘油三酯"
        },
        {
          "source": "drug_beta_blockers",
          "target": "Severe_hypertriglyceridaemia",
          "relation": "inhibits",
          "weight": 0.4,
          "agent": "Proponent",
          "rationale": "某些β-阻滞剂影响脂质代谢"
        },
        {
          "source": "drug_progestins",
          "target": "Severe_hypertriglyceridaemia",
          "relation": "inhibits",
          "weight": 0.3,
          "agent": "Proponent",
          "rationale": "有潜在影响糖脂代谢"
        },
        {
          "source": "drug_gemfibrozil",
          "target": "n_rp_gemfibrozil",
          "relation": "involved_in",
          "weight": 0.8,
          "agent": "Skeptic",
          "rationale": "已知导致高甘油三酯风险"
        },
        {
          "source": "n_rp_gemfibrozil",
          "target": "n_adv_gemfibrozil",
          "relation": "causes",
          "weight": 0.8,
          "agent": "Skeptic",
          "rationale": "可能导致严重的不良表型"
        },
        {
          "source": "n_adv_gemfibrozil",
          "target": "H1",
          "relation": "refutes",
          "weight": 0.85,
          "agent": "Skeptic",
          "rationale": "支持风险链，抵消预计益处"
        },
        {
          "source": "drug_fenofibrate",
          "target": "n_rp_fenofibrate",
          "relation": "involved_in",
          "weight": 0.8,
          "agent": "Skeptic",
          "rationale": "已知导致高甘油三酯风险"
        },
        {
          "source": "n_rp_fenofibrate",
          "target": "n_adv_fenofibrate",
          "relation": "causes",
          "weight": 0.8,
          "agent": "Skeptic",
          "rationale": "可能导致严重的不良表型"
        },
        {
          "source": "n_adv_fenofibrate",
          "target": "H2",
          "relation": "refutes",
          "weight": 0.85,
          "agent": "Skeptic",
          "rationale": "支持风险链，抵消预计益处"
        },
        {
          "source": "drug_clofibrate",
          "target": "n_rp_clofibrate",
          "relation": "involved_in",
          "weight": 0.8,
          "agent": "Skeptic",
          "rationale": "已知导致高甘油三酯风险"
        },
        {
          "source": "n_rp_clofibrate",
          "target": "n_adv_clofibrate",
          "relation": "causes",
          "weight": 0.8,
          "agent": "Skeptic",
          "rationale": "可能导致严重的不良表型"
        },
        {
          "source": "n_adv_clofibrate",
          "target": "H3",
          "relation": "refutes",
          "weight": 0.85,
          "agent": "Skeptic",
          "rationale": "支持风险链，抵消预计益处"
        },
        {
          "source": "drug_niacin",
          "target": "n_rp_niacin",
          "relation": "involved_in",
          "weight": 0.8,
          "agent": "Skeptic",
          "rationale": "已知导致高甘油三酯风险"
        },
        {
          "source": "n_rp_niacin",
          "target": "n_adv_niacin",
          "relation": "causes",
          "weight": 0.8,
          "agent": "Skeptic",
          "rationale": "可能导致严重的不良表型"
        },
        {
          "source": "n_adv_niacin",
          "target": "H4",
          "relation": "refutes",
          "weight": 0.85,
          "agent": "Skeptic",
          "rationale": "支持风险链，抵消预计益处"
        },
        {
          "source": "drug_estrogens",
          "target": "n_rp_estrogens",
          "relation": "involved_in",
          "weight": 0.8,
          "agent": "Skeptic",
          "rationale": "已知导致高甘油三酯风险"
        },
        {
          "source": "n_rp_estrogens",
          "target": "n_adv_estrogens",
          "relation": "causes",
          "weight": 0.8,
          "agent": "Skeptic",
          "rationale": "可能导致严重的不良表型"
        },
        {
          "source": "n_adv_estrogens",
          "target": "H5",
          "relation": "refutes",
          "weight": 0.85,
          "agent": "Skeptic",
          "rationale": "支持风险链，抵消预计益处"
        },
        {
          "source": "drug_thiazolidinediones",
          "target": "n_rp_thiazolidinediones",
          "relation": "involved_in",
          "weight": 0.8,
          "agent": "Skeptic",
          "rationale": "已知导致高甘油三酯风险"
        },
        {
          "source": "n_rp_thiazolidinediones",
          "target": "n_adv_thiazolidinediones",
          "relation": "causes",
          "weight": 0.8,
          "agent": "Skeptic",
          "rationale": "可能导致严重的不良表型"
        },
        {
          "source": "n_adv_thiazolidinediones",
          "target": "H6",
          "relation": "refutes",
          "weight": 0.85,
          "agent": "Skeptic",
          "rationale": "支持风险链，抵消预计益处"
        },
        {
          "source": "drug_sodium_glucose_cotransporter_2_inhibitors",
          "target": "n_rp_sodium_glucose_cotransporter_2_inhibitors",
          "relation": "involved_in",
          "weight": 0.8,
          "agent": "Skeptic",
          "rationale": "已知导致高甘油三酯风险"
        },
        {
          "source": "n_rp_sodium_glucose_cotransporter_2_inhibitors",
          "target": "n_adv_sodium_glucose_cotransporter_2_inhibitors",
          "relation": "causes",
          "weight": 0.8,
          "agent": "Skeptic",
          "rationale": "可能导致严重的不良表型"
        },
        {
          "source": "n_adv_sodium_glucose_cotransporter_2_inhibitors",
          "target": "H7",
          "relation": "refutes",
          "weight": 0.85,
          "agent": "Skeptic",
          "rationale": "支持风险链，抵消预计益处"
        },
        {
          "source": "drug_corticosteroids",
          "target": "n_rp_corticosteroids",
          "relation": "involved_in",
          "weight": 0.8,
          "agent": "Skeptic",
          "rationale": "已知导致高甘油三酯风险"
        },
        {
          "source": "n_rp_corticosteroids",
          "target": "n_adv_corticosteroids",
          "relation": "causes",
          "weight": 0.8,
          "agent": "Skeptic",
          "rationale": "可能导致严重的不良表型"
        },
        {
          "source": "n_adv_corticosteroids",
          "target": "H8",
          "relation": "refutes",
          "weight": 0.85,
          "agent": "Skeptic",
          "rationale": "支持风险链，抵消预计益处"
        },
        {
          "source": "drug_bosentan",
          "target": "n_rp_bosentan",
          "relation": "involved_in",
          "weight": 0.8,
          "agent": "Skeptic",
          "rationale": "已知导致高甘油三酯风险"
        },
        {
          "source": "n_rp_bosentan",
          "target": "n_adv_bosentan",
          "relation": "causes",
          "weight": 0.8,
          "agent": "Skeptic",
          "rationale": "可能导致严重的不良表型"
        },
        {
          "source": "n_adv_bosentan",
          "target": "H9",
          "relation": "refutes",
          "weight": 0.85,
          "agent": "Skeptic",
          "rationale": "支持风险链，抵消预计益处"
        },
        {
          "source": "drug_glitazones",
          "target": "n_rp_glitazones",
          "relation": "involved_in",
          "weight": 0.8,
          "agent": "Skeptic",
          "rationale": "已知导致高甘油三酯风险"
        },
        {
          "source": "n_rp_glitazones",
          "target": "n_adv_glitazones",
          "relation": "causes",
          "weight": 0.8,
          "agent": "Skeptic",
          "rationale": "可能导致严重的不良表型"
        },
        {
          "source": "n_adv_glitazones",
          "target": "H10",
          "relation": "refutes",
          "weight": 0.85,
          "agent": "Skeptic",
          "rationale": "支持风险链，抵消预计益处"
        },
        {
          "source": "drug_beta_blockers",
          "target": "n_rp_beta_blockers",
          "relation": "involved_in",
          "weight": 0.8,
          "agent": "Skeptic",
          "rationale": "已知导致高甘油三酯风险"
        },
        {
          "source": "n_rp_beta_blockers",
          "target": "n_adv_beta_blockers",
          "relation": "causes",
          "weight": 0.8,
          "agent": "Skeptic",
          "rationale": "可能导致严重的不良表型"
        },
        {
          "source": "n_adv_beta_blockers",
          "target": "H11",
          "relation": "refutes",
          "weight": 0.85,
          "agent": "Skeptic",
          "rationale": "支持风险链，抵消预计益处"
        },
        {
          "source": "drug_progestins",
          "target": "n_rp_progestins",
          "relation": "involved_in",
          "weight": 0.8,
          "agent": "Skeptic",
          "rationale": "已知导致高甘油三酯风险"
        },
        {
          "source": "n_rp_progestins",
          "target": "n_adv_progestins",
          "relation": "causes",
          "weight": 0.8,
          "agent": "Skeptic",
          "rationale": "可能导致严重的不良表型"
        },
        {
          "source": "n_adv_progestins",
          "target": "H12",
          "relation": "refutes",
          "weight": 0.85,
          "agent": "Skeptic",
          "rationale": "支持风险链，抵消预计益处"
        }
      ],
      "round_index": 2
    },
    "history": {
      "round": 2,
      "last_scores": [
        {
          "hypothesis_id": "H1",
          "score": 0.25,
          "components": {
            "mechanism_fit": 0.2,
            "class_prior": 0.3,
            "pk_pd_feasibility": 0.6,
            "indication_plausibility": 0.4,
            "safety_risk": 0.85,
            "graph_bonus": 0.0,
            "conflict_penalty": 0.85
          },
          "graph_signals": {
            "support_weight": 0.8,
            "contradiction_weight": 0.85,
            "mechanistic_connectivity": false,
            "path_disjointness": 0,
            "conflict_hotspots": [
              {
                "topic": "Risk of severe hypertriglyceridaemia",
                "pro": [
                  "H1"
                ],
                "con": [
                  "n_adv_gemfibrozil"
                ]
              }
            ]
          },
          "rationales": {
            "mechanism_fit": [
              "Gemfibrozil抑制高甘油三酯血症，但同时存在安全性风险加重的证据。"
            ],
            "safety_risk": [
              "存在显著的安全性问题，包括潜在导致严重不良反应的链条。"
            ]
          },
          "confidence": "low",
          "uncertainties": [
            "目前安全性担忧显著影响补充解释的可能性。"
          ]
        },
        {
          "hypothesis_id": "H2",
          "score": 0.25,
          "components": {
            "mechanism_fit": 0.2,
            "class_prior": 0.3,
            "pk_pd_feasibility": 0.6,
            "indication_plausibility": 0.4,
            "safety_risk": 0.85,
            "graph_bonus": 0.0,
            "conflict_penalty": 0.85
          },
          "graph_signals": {
            "support_weight": 0.8,
            "contradiction_weight": 0.85,
            "mechanistic_connectivity": false,
            "path_disjointness": 0,
            "conflict_hotspots": [
              {
                "topic": "Risk of severe hypertriglyceridaemia",
                "pro": [
                  "H2"
                ],
                "con": [
                  "n_adv_fenofibrate"
                ]
              }
            ]
          },
          "rationales": {
            "mechanism_fit": [
              "Fenofibrate抑制高甘油三酯血症，但同时存在安全性风险。"
            ],
            "safety_risk": [
              "存在显著的安全性问题，包括潜在导致严重不良反应的链条。"
            ]
          },
          "confidence": "low",
          "uncertainties": [
            "目前安全性担忧显著影响补充解释的可能性。"
          ]
        },
        {
          "hypothesis_id": "H3",
          "score": 0.25,
          "components": {
            "mechanism_fit": 0.2,
            "class_prior": 0.3,
            "pk_pd_feasibility": 0.6,
            "indication_plausibility": 0.4,
            "safety_risk": 0.85,
            "graph_bonus": 0.0,
            "conflict_penalty": 0.85
          },
          "graph_signals": {
            "support_weight": 0.7,
            "contradiction_weight": 0.85,
            "mechanistic_connectivity": false,
            "path_disjointness": 0,
            "conflict_hotspots": [
              {
                "topic": "Risk of severe hypertriglyceridaemia",
                "pro": [
                  "H3"
                ],
                "con": [
                  "n_adv_clofibrate"
                ]
              }
            ]
          },
          "rationales": {
            "mechanism_fit": [
              "Clofibrate抑制高甘油三酯血症，但同时存在安全性风险。"
            ],
            "safety_risk": [
              "存在显著的安全性问题，包括潜在导致严重不良反应的链条。"
            ]
          },
          "confidence": "low",
          "uncertainties": [
            "目前安全性担忧显著影响补充解释的可能性。"
          ]
        },
        {
          "hypothesis_id": "H4",
          "score": 0.25,
          "components": {
            "mechanism_fit": 0.2,
            "class_prior": 0.3,
            "pk_pd_feasibility": 0.6,
            "indication_plausibility": 0.4,
            "safety_risk": 0.85,
            "graph_bonus": 0.0,
            "conflict_penalty": 0.85
          },
          "graph_signals": {
            "support_weight": 0.7,
            "contradiction_weight": 0.85,
            "mechanistic_connectivity": false,
            "path_disjointness": 0,
            "conflict_hotspots": [
              {
                "topic": "Risk of severe hypertriglyceridaemia",
                "pro": [
                  "H4"
                ],
                "con": [
                  "n_adv_niacin"
                ]
              }
            ]
          },
          "rationales": {
            "mechanism_fit": [
              "Niacin抑制高甘油三酯血症，但同时存在安全性风险。"
            ],
            "safety_risk": [
              "存在显著的安全性问题，包括潜在导致严重不良反应的链条。"
            ]
          },
          "confidence": "low",
          "uncertainties": [
            "目前安全性担忧显著影响补充解释的可能性。"
          ]
        },
        {
          "hypothesis_id": "H5",
          "score": 0.25,
          "components": {
            "mechanism_fit": 0.2,
            "class_prior": 0.3,
            "pk_pd_feasibility": 0.6,
            "indication_plausibility": 0.4,
            "safety_risk": 0.85,
            "graph_bonus": 0.0,
            "conflict_penalty": 0.85
          },
          "graph_signals": {
            "support_weight": 0.6,
            "contradiction_weight": 0.85,
            "mechanistic_connectivity": false,
            "path_disjointness": 0,
            "conflict_hotspots": [
              {
                "topic": "Risk of severe hypertriglyceridaemia",
                "pro": [
                  "H5"
                ],
                "con": [
                  "n_adv_estrogens"
                ]
              }
            ]
          },
          "rationales": {
            "mechanism_fit": [
              "雌激素抑制高甘油三酯血症，但同时存在安全性风险。"
            ],
            "safety_risk": [
              "存在显著的安全性问题，包括潜在导致严重不良反应的链条。"
            ]
          },
          "confidence": "low",
          "uncertainties": [
            "目前安全性担忧显著影响补充解释的可能性。"
          ]
        },
        {
          "hypothesis_id": "H6",
          "score": 0.25,
          "components": {
            "mechanism_fit": 0.2,
            "class_prior": 0.3,
            "pk_pd_feasibility": 0.6,
            "indication_plausibility": 0.4,
            "safety_risk": 0.85,
            "graph_bonus": 0.0,
            "conflict_penalty": 0.85
          },
          "graph_signals": {
            "support_weight": 0.5,
            "contradiction_weight": 0.85,
            "mechanistic_connectivity": false,
            "path_disjointness": 0,
            "conflict_hotspots": [
              {
                "topic": "Risk of severe hypertriglyceridaemia",
                "pro": [
                  "H6"
                ],
                "con": [
                  "n_adv_thiazolidinediones"
                ]
              }
            ]
          },
          "rationales": {
            "mechanism_fit": [
              "噻唑烷二酮抑制高甘油三酯血症，但同时存在安全性风险。"
            ],
            "safety_risk": [
              "存在显著的安全性问题，包括潜在导致严重不良反应的链条。"
            ]
          },
          "confidence": "low",
          "uncertainties": [
            "目前安全性担忧显著影响补充解释的可能性。"
          ]
        },
        {
          "hypothesis_id": "H7",
          "score": 0.25,
          "components": {
            "mechanism_fit": 0.2,
            "class_prior": 0.3,
            "pk_pd_feasibility": 0.6,
            "indication_plausibility": 0.4,
            "safety_risk": 0.85,
            "graph_bonus": 0.0,
            "conflict_penalty": 0.85
          },
          "graph_signals": {
            "support_weight": 0.5,
            "contradiction_weight": 0.85,
            "mechanistic_connectivity": false,
            "path_disjointness": 0,
            "conflict_hotspots": [
              {
                "topic": "Risk of severe hypertriglyceridaemia",
                "pro": [
                  "H7"
                ],
                "con": [
                  "n_adv_sodium_glucose_cotransporter_2_inhibitors"
                ]
              }
            ]
          },
          "rationales": {
            "mechanism_fit": [
              "钠葡萄糖共转运体抑制剂抑制高甘油三酯血症，但同时存在安全性风险。"
            ],
            "safety_risk": [
              "存在显著的安全性问题，包括潜在导致严重不良反应的链条。"
            ]
          },
          "confidence": "low",
          "uncertainties": [
            "目前安全性担忧显著影响补充解释的可能性。"
          ]
        },
        {
          "hypothesis_id": "H8",
          "score": 0.25,
          "components": {
            "mechanism_fit": 0.2,
            "class_prior": 0.3,
            "pk_pd_feasibility": 0.6,
            "indication_plausibility": 0.4,
            "safety_risk": 0.85,
            "graph_bonus": 0.0,
            "conflict_penalty": 0.85
          },
          "graph_signals": {
            "support_weight": 0.4,
            "contradiction_weight": 0.85,
            "mechanistic_connectivity": false,
            "path_disjointness": 0,
            "conflict_hotspots": [
              {
                "topic": "Risk of severe hypertriglyceridaemia",
                "pro": [
                  "H8"
                ],
                "con": [
                  "n_adv_corticosteroids"
                ]
              }
            ]
          },
          "rationales": {
            "mechanism_fit": [
              "皮质类固醇抑制高甘油三酯血症，但同时存在安全性风险。"
            ],
            "safety_risk": [
              "存在显著的安全性问题，包括潜在导致严重不良反应的链条。"
            ]
          },
          "confidence": "low",
          "uncertainties": [
            "目前安全性担忧显著影响补充解释的可能性。"
          ]
        },
        {
          "hypothesis_id": "H9",
          "score": 0.25,
          "components": {
            "mechanism_fit": 0.2,
            "class_prior": 0.3,
            "pk_pd_feasibility": 0.6,
            "indication_plausibility": 0.4,
            "safety_risk": 0.85,
            "graph_bonus": 0.0,
            "conflict_penalty": 0.85
          },
          "graph_signals": {
            "support_weight": 0.4,
            "contradiction_weight": 0.85,
            "mechanistic_connectivity": false,
            "path_disjointness": 0,
            "conflict_hotspots": [
              {
                "topic": "Risk of severe hypertriglyceridaemia",
                "pro": [
                  "H9"
                ],
                "con": [
                  "n_adv_bosentan"
                ]
              }
            ]
          },
          "rationales": {
            "mechanism_fit": [
              "博塞坦抑制高甘油三酯血症，但同时存在安全性风险。"
            ],
            "safety_risk": [
              "存在显著的安全性问题，包括潜在导致严重不良反应的链条。"
            ]
          },
          "confidence": "low",
          "uncertainties": [
            "目前安全性担忧显著影响补充解释的可能性。"
          ]
        },
        {
          "hypothesis_id": "H10",
          "score": 0.25,
          "components": {
            "mechanism_fit": 0.2,
            "class_prior": 0.3,
            "pk_pd_feasibility": 0.6,
            "indication_plausibility": 0.4,
            "safety_risk": 0.85,
            "graph_bonus": 0.0,
            "conflict_penalty": 0.85
          },
          "graph_signals": {
            "support_weight": 0.4,
            "contradiction_weight": 0.85,
            "mechanistic_connectivity": false,
            "path_disjointness": 0,
            "conflict_hotspots": [
              {
                "topic": "Risk of severe hypertriglyceridaemia",
                "pro": [
                  "H10"
                ],
                "con": [
                  "n_adv_glitazones"
                ]
              }
            ]
          },
          "rationales": {
            "mechanism_fit": [
              "噻唑烷二酮抑制高甘油三酯血症，但同时存在安全性风险。"
            ],
            "safety_risk": [
              "存在显著的安全性问题，包括潜在导致严重不良反应的链条。"
            ]
          },
          "confidence": "low",
          "uncertainties": [
            "目前安全性担忧显著影响补充解释的可能性。"
          ]
        },
        {
          "hypothesis_id": "H11",
          "score": 0.25,
          "components": {
            "mechanism_fit": 0.2,
            "class_prior": 0.3,
            "pk_pd_feasibility": 0.6,
            "indication_plausibility": 0.4,
            "safety_risk": 0.85,
            "graph_bonus": 0.0,
            "conflict_penalty": 0.85
          },
          "graph_signals": {
            "support_weight": 0.4,
            "contradiction_weight": 0.85,
            "mechanistic_connectivity": false,
            "path_disjointness": 0,
            "conflict_hotspots": [
              {
                "topic": "Risk of severe hypertriglyceridaemia",
                "pro": [
                  "H11"
                ],
                "con": [
                  "n_adv_beta_blockers"
                ]
              }
            ]
          },
          "rationales": {
            "mechanism_fit": [
              "β-阻滞剂抑制高甘油三酯血症，但同时存在安全性风险。"
            ],
            "safety_risk": [
              "存在显著的安全性问题，包括潜在导致严重不良反应的链条。"
            ]
          },
          "confidence": "low",
          "uncertainties": [
            "目前安全性担忧显著影响补充解释的可能性。"
          ]
        },
        {
          "hypothesis_id": "H12",
          "score": 0.25,
          "components": {
            "mechanism_fit": 0.2,
            "class_prior": 0.3,
            "pk_pd_feasibility": 0.6,
            "indication_plausibility": 0.4,
            "safety_risk": 0.85,
            "graph_bonus": 0.0,
            "conflict_penalty": 0.85
          },
          "graph_signals": {
            "support_weight": 0.3,
            "contradiction_weight": 0.85,
            "mechanistic_connectivity": false,
            "path_disjointness": 0,
            "conflict_hotspots": [
              {
                "topic": "Risk of severe hypertriglyceridaemia",
                "pro": [
                  "H12"
                ],
                "con": [
                  "n_adv_progestins"
                ]
              }
            ]
          },
          "rationales": {
            "mechanism_fit": [
              "孕激素抑制高甘油三酯血症，但同时存在安全性风险。"
            ],
            "safety_risk": [
              "存在显著的安全性问题，包括潜在导致严重不良反应的链条。"
            ]
          },
          "confidence": "low",
          "uncertainties": [
            "目前安全性担忧显著影响补充解释的可能性。"
          ]
        }
      ]
    },
    "thresholds": {
      "stop_delta": 0.03,
      "saturation_ratio": 0.65,
      "weights": {
        "path_disjointness": 1.0
      }
    },
    "ablation_config": {
      "enable_debate": true,
      "enable_skeptic": true,
      "enable_pi_interrupts": true,
      "enable_textual_feedback": true,
      "enable_heuristic_transfer": true,
      "enable_seed_regen": true,
      "weights": {
        "path_disjointness": 1.0
      },
      "mode": "graph"
    }
  },
  "output": {
    "revisions": [
      {
        "hypothesis_id": "H1",
        "graph_actions": [
          {
            "type": "stress_test_safety",
            "topic": "Gemfibrozil对高甘油三酯血症的安全性问题",
            "expectation": "若风险成立，标注高权重 refutes 边",
            "assignee": "Skeptic"
          }
        ],
        "debate_focus": [
          "Gemfibrozil在高甘油三酯血症的长期安全性与短期疗效异质性",
          "明确Gemfibrozil的相对风险与获益"
        ]
      },
      {
        "hypothesis_id": "H2",
        "graph_actions": [
          {
            "type": "stress_test_safety",
            "topic": "Fenofibrate对高甘油三酯血症的安全性问题",
            "expectation": "若风险成立，标注高权重 refutes 边",
            "assignee": "Skeptic"
          }
        ],
        "debate_focus": [
          "Fenofibrate对高甘油三酯血症的影响及潜在风险",
          "Fenofibrate的长期疗效与安全性比较"
        ]
      },
      {
        "hypothesis_id": "H3",
        "graph_actions": [
          {
            "type": "stress_test_safety",
            "topic": "Clofibrate对高甘油三酯血症的安全性问题",
            "expectation": "若风险成立，标注高权重 refutes 边",
            "assignee": "Skeptic"
          }
        ],
        "debate_focus": [
          "Clofibrate的使用限制及其风险",
          "Clofibrate在高甘油三酯血症中是否值得使用"
        ]
      },
      {
        "hypothesis_id": "H4",
        "graph_actions": [
          {
            "type": "stress_test_safety",
            "topic": "Niacin对高甘油三酯血症的安全性问题",
            "expectation": "若风险成立，标注高权重 refutes 边",
            "assignee": "Skeptic"
          }
        ],
        "debate_focus": [
          "Niacin在高甘油三酯血症治疗中的角色",
          "Niacin与其他药物的安全性比较"
        ]
      },
      {
        "hypothesis_id": "H5",
        "graph_actions": [
          {
            "type": "stress_test_safety",
            "topic": "Estrogens对高甘油三酯血症的影响",
            "expectation": "若风险成立，标注高权重 refutes 边",
            "assignee": "Skeptic"
          }
        ],
        "debate_focus": [
          "Estrogens对高甘油三酯的影响及潜在副作用",
          "Estrogens在糖脂代谢中的角色"
        ]
      },
      {
        "hypothesis_id": "H6",
        "graph_actions": [
          {
            "type": "stress_test_safety",
            "topic": "Thiazolidinediones对高甘油三酯血症的影响",
            "expectation": "若风险成立，标注高权重 refutes 边",
            "assignee": "Skeptic"
          }
        ],
        "debate_focus": [
          "Thiazolidinediones的应用及其风险",
          "Thiazolidinediones的治疗效果与安全性"
        ]
      }
    ],
    "seed_request": {
      "should_regenerate": true,
      "reason": "所有假设的机制连通性不足，且支持与反对证据均较为集中，缺乏多样性。",
      "n": 4
    }
  }
}